BridgeMD
New treatment option for Alzheimer Disease
Official title Open-Label Extension Protocol to SNK01-AD01 Study
ClinicalTrials.gov ID: NCT07228078
What this study is testing
What is SNK01?
SNK01 is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for alzheimer disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Open-Label Extension Protocol to SNK01-AD01 Study
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- Participants will be considered eligible for participation in the study if all the following criteria are satisfied:
- The participant or their legally authorized representative must be willing and able to give their informed consent in writing and comply with the...
- Participants must have a reliable study partner/caregiver (per investigator judgement for instance a family member, partner etc., guardian (must be...
- Participants previously completed participation in study SNK01-AD01.
You likely can't join if
- Participants who fulfill any of the following criteria will not be recruited into the study:
- Any participant whose safety the investigator considers to be at risk from this trial's intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Glendale, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Glendale, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.